-
At least 72 died in Spain's Ceuta migrant rush, Spain says
-
Zverev says sanctions won't solve problem of bloated Masters events
-
Russian teen Liutova wins WTA Memphis title
-
Brazil's Lula, 80, says 'in great shape' as he launches fourth term bid
-
Zverev remains wary of 12-day Masters events
-
Barco joins Chelsea rebuild from Strasbourg
-
Wimbledon champ Noskova ready for 'new opportunity'
-
Commonwealth Games faces uncertain future ahead of centenary edition
-
Japan's Kuwaki wins women's British Open to clinch first major title
-
Moroccans gather at Ceuta border, desperate for news of loved ones
-
Sabalenka aims to bounce back in Toronto after Wimbledon disappointment
-
Finucane seals fourth cycling gold on final day of Commonwealth Games
-
Iran says close to Hormuz deal with Oman, after US suspends attack plan
-
At Nepal school, outpouring of grief for climber Nirmal Purja
-
'Spider-Man' soars to huge $355 million opening in North America
-
Tourists slowly return to French bay opposite huge wildfire
-
Handbag tosses and high-heeled sprints: Amsterdam celebrates Drag Olympics
-
Helicopter crew killed in Greece fires
-
Trump's on-again-off-again war against Iran: in his own words
-
Wiebes takes dominant second win at Tour de France Femmes
-
Dodgers land Tigers pitching ace Skubal in MLB trade deadline blockbuster
-
Suicide attack kills 13 during protest in northern Pakistan: police
-
Infantino struggling to survive, says former IOC marketing chief
-
Helicopters collide in Greece as fires spread
-
OPEC+ boosts September production by 188,000 barrels/day
-
Power returns to Cuba's west after grid failure
-
Rescuers recover climber Nirmal Purja's body after avalanche disaster
-
At least 72 died in Spain's Ceuta migrant rush
-
Fire toll mounts in Greece as blazes spread
-
South Korea records its highest-ever temperature of 42.5C
-
Sri Lanka deploys troops after prison riot
-
Trump says US, Israel to hold off on Iran strikes
-
Baltics transform from Soviet stagnation to startup hubs
-
Messi returns as Inter Miami draw 2-2 against Columbus Crew
-
AI keeps consumer prices high in 'RAMaggedon' chip crunch
-
Five of Cuba's 15 provinces without power as grid fails again
-
Dressel, Walsh win 50m free titles at US Swimming Championships
-
Baltic startups take aim at deterring Russia on NATO's eastern flank
-
OPEC+ tipped to raise production again but new quotas loom
-
Tourists chase high-octane thrill in China's trending biker capital
-
De Zerbi unsure over Richarlison's future at Spurs
-
Vincent Pastore, who played 'Big Pussy' on 'The Sopranos,' dead at 80
-
Tottenham manager De Zerbi 'happy' with pre-season progress
-
Lula, Brazil's political titan, races against time
-
Brazil's Lula launches fourth term bid as Trump looms over campaign
-
When rogue AI launches a cyberattack, who is legally responsible?
-
Alonso welcomes Mudryk's Chelsea return after doping ban
-
Venezuela transition talks to start in person next week: govt
-
'Damn hot': Last summer for Japan cosplay extravaganza
-
Colombia truck bomb wounds 14 ahead of presidential inauguration
Animal testing put to the test in Swiss vote
Switzerland goes to the polls Sunday to decide whether animal and human testing should be banned -- a proposal that has triggered an outcry in a country heavily reliant on big pharma.
Opinions suggest that the proposal by animal rights defenders is highly unlikely to pass.
But if it did, "Switzerland would be the only country internationally with such a ban," said Yves Fluckiger, president of the Swiss universities lobby group.
Researchers insist that medical progress is impossible without experimentation.
At the University of Geneva, Patrycja Nowak-Sliwinska, head of the molecular pharmacology laboratory, unveils her cell incubator where intestinal organoids from cancer patients are being cultivated.
These structures, made up of cells, make it possible to test a large number of potential treatments.
"With the in vitro model, we try to find promising candidates" -- and only the latter would then be tested on animals, said Nowak-Sliwinska, who received a prize rewarding researchers who work to replace animals with other methods.
But even she said it would be impossible to do all the research without animal experimentation and clinical trials.
This is why the university's Faculty of Medicine has an animal facility in the basement housing some 25,000 animals -- mostly mice and rats.
- Strict protocols -
Inside, Professor Doron Merkler conducts research to find a treatment for a form of multiple sclerosis.
The research could not advance without using mice, into which he injects modified cells to observe how the disease affects the nervous system.
The mouse he is working on is showing symptoms: instability, difficulty moving, and partial paralysis of the limbs.
The experiments are framed by a strict protocol regarding their degree of severity, and animal keepers are trained to detect when an animal is not well.
"If no veterinary care can be provided to the animal, we can decide with the researcher to sacrifice it," said Pierre Bonnaventure, head of animal facilities at the faculty.
In Switzerland, researchers seeking to use live animals must make a formal request, establish that there is no alternative method available and that the conditions imposed on the animals will be as light as possible.
The number of animals used has consequently fallen sharply, from nearly two million per year in the early 1980s to around 560,000.
Some 20,000 animals a year undergo severe interventions, such as the implantation of a tumour, according to federal authorities.
- Proposal 'goes too far' -
Under Switzerland's direct democracy system, campaigners collected enough signatures to trigger a popular vote.
The proposal would outlaw experiments not only on animals but on humans too, as well as ban the importation of new drugs developed through such means.
"Animal experiments should be considered a crime," Renato Werndli, a doctor among those who launched the initiative, told AFP.
All the major political parties in Switzerland are against the proposal.
For the government, the ban "goes too far" and would have "serious consequences for health" -- and also for the economy, in a country where the chemical and pharmaceutical sector represents just over half of all exports.
Interpharma, the Swiss pharmaceutical industry's lobby group, warned that in the event of a ban, "the institutions and companies concerned would be forced to relocate their activities abroad".
Switzerland has already rejected three initiatives on the subject -- in 1985 (70 percent), 1992 (56 percent) and 1993 (72 percent) -- and is expected to do likewise this time.
But it remains to be seen whether the majority will be as big, in a society where animal welfare has grown in importance.
For Samia Hurst, a bioethicist at the University of Geneva, the new initiative commits "a fairly frequent mistake, which is to target biomedical research".
However, she told AFP: "Animal experimentation, among the various uses that humanity makes of other species, is both the most closely monitored and undoubtedly the most justified."
F.Müller--BTB